Andere Sprachen IDEXX Laboratories, Inc.

Aktien

888210

US45168D1046

IDXX

Medizinische Versorgung

Markt geschlossen - Nasdaq Andere Börsenplätze 19:00:00 29.11.2024			% 5 Tage	% 1. Jan.
421,75 ^USD	-0,00 %		+1,08 %	-24,02 %

21.11.	IDEXX Laboratories CFO Brian McKeon geht in den Ruhestand; Andrew Emerson als Nachfolger ernannt	MT
21.11.	IDEXX Laboratories, Inc. kündigt Änderungen in der Geschäftsführung an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

IDEXX Announces CFO Transition - IDEXX US	22.11.
IDEXX Laboratories CFO Brian McKeon to Retire; Andrew Emerson Named Successor	21.11.
IDEXX Laboratories : Announces CFO Transition Form 8 K	21.11.
IDEXX Announces CFO Transition	21.11.
IDEXX Laboratories, Inc. Announces Executive Changes	21.11.
IDEXX Laboratories, Inc. Announces Chief Financial Officer Changes	21.11.
IDEXX Laboratories, Inc. Announces Resignation of Jonathan W. Ayers from the Board and Finance Committee	12.11.
IDEXX Laboratories Announces Third Quarter Results	01.11.
Earnings Flash (IDXX) IDEXX LABORATORIES Reports Q3 Revenue $975.5M	31.10.
IDEXX Laboratories' Q3 Earnings, Revenue Rise; Fiscal 2024 Outlook Updated	31.10.
IDEXX Laboratories : Q3 2024 Earnings Snapshot	31.10.
IDEXX Laboratories : Achieves third quarter revenue growth of 7% as reported and 6% organic, supported by CAG Diagnostics recurring revenue growth of 7% as reported and organic Form 8 K	31.10.
Idexx: Q3 Earnings Snapshot	31.10.
Earnings Flash (IDXX) IDEXX LABORATORIES Posts Q3 Revenue $975.5M	31.10.
Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999.	31.10.
IDEXX Laboratories, Inc. Updates Earnings Guidance for the Full Year of 2024	31.10.
IDEXX Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	31.10.
CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results	31.10.
IDEXX Laboratories to Release 2024 Third Quarter Financial Results	30.09.
IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference	21.08.
Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999.	06.08.
IDEXX Labs cuts annual forecast as vet visits remain slow	06.08.
IDEXX Laboratories Q2 Adjusted Earnings, Revenue Rise; Lowers 2024 Revenue Guidance	06.08.
IDEXX Laboratories : Q2 2024 Earnings Snapshot	06.08.
Earnings Flash (IDXX) IDEXX LABORATORIES Reports Q2 Revenue $1B, vs. Street Est of $1B	06.08.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen IDEXX Laboratories, Inc.

Aktien

888210

US45168D1046

IDXX

Medizinische Versorgung

Andere Sprachen

Filter